Edward G. Shaw

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)”.

Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)

Journal of Clinical Oncology(2024)10.1200/jco.23.01100

N/A

0.648DataRank · unranked

21 citations

Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King +6 more

Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

Neuro-Oncology(2020)10.1093/neuonc/noaa021

N/A

0DataRank · unranked

59 citations

S. Keith Anderson, Xiomara W. Carrero, Paul D. Brown, Karla V. Ballman, Brian Patrick O’Neill +8 more

Phase 3 randomized placebo-controlled trial of donepezil for late cancer-related cognitive impairment in breast cancer survivors exposed to chemotherapy from the Wake Forest NCORP Research Base REMEMBER trial (WF97116).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12004

N/A

0DataRank · unranked

7 citations

Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King +6 more

Phase 3 randomized placebo-controlled trial of donepezil for cancer-related cognitive impairment among breast cancer survivors: Results on patient-reported cognitive function from the wake forest nCI community oncology research program (NCORP) research base REMEMBER trial (WF97116).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12076

N/A

0DataRank · unranked

1 citations

Emily V. Dressler, W. Mark Brown, Glenn J. Lesser, William P. Fusselman, Vinay Gudena +5 more

Data from A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

(2023)10.1158/0008-5472.c.6494621

N/A

0DataRank · unranked

0 citations

Hilary Blair, Karla V. Ballman, Caterina Giannini, Robert M. Arusell, Mark E. Law +7 more